Noul Co.,Ltd. (KOSDAQ:376930)

Market Cap	80.36B
Revenue (ttm)	3.91B
Net Income (ttm)	-20.20B
Shares Out	36.95M
EPS (ttm)	-546.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	674,404
Average Volume	3,396,316
Open	2,280.00
Previous Close	2,280.00
Day's Range	2,205.00 - 2,280.00
52-Week Range	1,810.00 - 4,190.00
Beta	-0.47
RSI	40.08
Earnings Date	Nov 11, 2025

About Noul Co.,Ltd.

Noul Co.,Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, and immunohistochemistry services. Noul Co.,Ltd. was founded in 2015 and is headquartered in Yongin-si, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 376930

Financial Performance

In 2024, Noul Co.,Ltd.'s revenue was 1.60 billion, a decrease of -41.42% compared to the previous year's 2.73 billion. Losses were -22.47 billion, 37.7% more than in 2023.